DCL logo

Cuu Long Pharmaceutical Joint Stock Company Stock Price

HOSE:DCL Community·₫4.1t Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

DCL Share Price Performance

₫0
-22250.00 (-100.00%)
₫0
-22250.00 (-100.00%)
Price ₫0

DCL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
0 Rewards

Cuu Long Pharmaceutical Joint Stock Company Key Details

₫1.3t

Revenue

₫1.1t

Cost of Revenue

₫204.2b

Gross Profit

₫184.7b

Other Expenses

₫19.5b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
267.20
15.45%
1.48%
49.6%
View Full Analysis

About DCL

Founded
1976
Employees
880
CEO
Huong Thi Nguyen
WebsiteView website
dcl.com.vn

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, nervous system, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, pharmacies, and drugstores. The company was founded in 1976 and is headquartered in Vinh Long, Vietnam. Cuu Long Pharmaceutical Joint Stock Company operates as a subsidiary of F.I.T Group Joint Stock Company.

Recent DCL News & Updates

Recent updates

No updates

Cuu Long Pharmaceutical Joint Stock Company Competitors